Relationship of androgens to muscle size and bone mineral density in womenwith polycystic ovary syndrome

Citation
T. Douchi et al., Relationship of androgens to muscle size and bone mineral density in womenwith polycystic ovary syndrome, OBSTET GYN, 98(3), 2001, pp. 445-449
Citations number
25
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
OBSTETRICS AND GYNECOLOGY
ISSN journal
00297844 → ACNP
Volume
98
Issue
3
Year of publication
2001
Pages
445 - 449
Database
ISI
SICI code
0029-7844(200109)98:3<445:ROATMS>2.0.ZU;2-5
Abstract
OBJECTIVE: To investigate the relationship of androgens to regional muscle size and bone mineral density (BMD) in women with polycystic ovary syndrome (PCOS). METHODS: Seventy-one amenorrheic and right-side dominant women with PCOS (m ean age +/- standard deviation 28.1 +/- 6.7 years) were enrolled. Baseline characteristics included age, height, weight, and body mass index (BMI). Re gional BAM and lean mass were measured by whole-body scanning with dual-ene rgy x-ray absorptiometry. Serum levels of testosterone, dehydroepiandroster one sulfate (DHEAS), and androstenedione were measured by radioimmunoassay. Correlations between regional BMD and variables were investigated using a Pearson correlation test and multiple regression analysis. RESULTS: Serum testosterone levels correlated significantly with lean mass of the left arm, right arm, trunk, left leg, and right leg (r = .34, P < .0 5 to r = .50, P < .01). Regional lean mass correlated significantly with re spective regional BMD (r = .30, P < .05 to r = .68, P < .001). These relati onships remained significant after adjusting for age, height, and weight. S erum testosterone levels were not correlated with BAM of the bilateral arms and lumbar spine. Although serum testosterone levels correlated with leg B MD (r = .34, P < .05 to r = .45, P < .01), significance did not persist aft er adjusting for respective regional lean mass. CONCLUSION: Testosterone influences regional BMD through increasing regiona l muscle mass in women with polycystic ovary syndrome. (C) 2001 by the Amer ican College of Obstetricians and Gynecologists.